BioHealth Capital Fund launched in DC area to help grow early stage life science companies
A little more than eight years after launching BioHealth Innovation to accelerate the commercialization of high potential scientist/entrepreneurs and companies within the BioHealth Capital Region (Maryland, Virginia and Washington, DC), the organization is taking a logical next step by creating a fund to support early stage companies.
The BioHealth Capital Fund, as the new vehicle is named, is raising $50 million that will be closed in two rounds of $25 million each. In a recent announcement, organizers said the fund currently has some existing investment candidates for its first close. Once the initial $50 million is raised, a second fund size to consider would be a $120 million round followed by a $250 million round.
You can read a much lengthier article here (BioHealth_Captial_Fund_Story).
